Your browser doesn't support javascript.
loading
50-years journey of heart transplant.
Kumar, Sameer; Tiwari, Nikhil; Singh, Saurabh; Chowdlu Kalappa, Kiran.
Afiliación
  • Kumar S; Consultant (Surgery) & CT Surgeon, Army Institute of Cardio Thoracic Sciences (AICTS), Pune, India.
  • Tiwari N; Consultant (Surgery) & CT Surgeon, Army Institute of Cardio Thoracic Sciences (AICTS), Pune, India.
  • Singh S; Senior Advisor (Surgery) & CT Surgeon, Army Institute of Cardio Thoracic Sciences (AICTS), Pune, India.
  • Chowdlu Kalappa K; Classified Specialist (Surgery) & CT Surgeon, Army Institute of Cardio Thoracic Sciences (AICTS), Pune, India.
Med J Armed Forces India ; 79(6): 616-620, 2023.
Article en En | MEDLINE | ID: mdl-37981922
Heart transplant is an established modality for the treatment of heart disease refractory to medical therapy. The last 50 years have seen the evolution of immune suppression therapy and standardization of protocols which have significantly improved outcomes following cardiac transplants. Donor availability is the main limiting factor and has restricted the number of heart transplants worldwide. Simultaneously, left ventricular assist devices have evolved to provide a "bridge" for recovery and transplant and alternatively as destination therapy to those waiting for the availability of a donor. This review article provides an overview of the current status of heart transplants after half a century and specific issues pertaining to our country.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Med J Armed Forces India Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Med J Armed Forces India Año: 2023 Tipo del documento: Article País de afiliación: India